Decongestant Drop Addiction: Causes, Symptoms, and Treatment of Drug-Induced Rhinitis

In everyday life, people often talk about "drip addiction," but in professional medicine, the term "drug-induced rhinitis" is commonly used for this condition. This refers to persistent nasal congestion that develops as a result of excessive or prolonged use of topical decongestants. Essentially, a person begins using the medication to relieve congestion, experiences a quick effect, and then experiences recurring congestion, leading to another run for the bottle. [1]

Strictly speaking, this isn't a classic chemical addiction in the same sense as addiction to nicotine, alcohol, or opioids. Current data hasn't shown that patients with rhinitis medicamentosa are automatically more prone to addictive behavior in general. But there is a behavioral component: a cycle of "short-term relief, then rebound congestion, then relapse" develops. This is why the word "addiction" has become so firmly established in everyday language. [2]

The problem arises primarily with long-term use of topical decongestants with vasoconstrictive action, such as oxymetazoline, xylometazoline, naphazoline, and phenylephrine. These medications quickly reduce mucosal swelling and work effectively for a short time, so the patient receives strong positive reinforcement after the first doses. The faster and more pronounced the relief, the higher the risk that the medication will be used not as a temporary aid, but as a daily aid for nasal breathing. [3]

Classic clinical reviews and textbooks indicate that problems can appear as early as 3 days, although other publications describe a wider range, up to 4-6 weeks of use. However, more recent reviews indicate that for modern imidazoline drugs, the risk may be lower than previously thought with strict short-term use. However, this nuance does not change the main rule of thumb: topical vasoconstrictors are intended for very short courses, not for continuous symptom control. [4]

It's especially important for patients to understand that decongestant drops almost never treat the underlying cause of chronic congestion. They temporarily reduce swelling, but they don't eliminate allergies, chronic inflammation, a deviated septum, polyps, or chronic rhinosinusitis. Therefore, if the underlying cause isn't identified and treated, the person quickly falls into a trap: the underlying condition persists, and drug-induced rhinitis is added to it. [5]

Below is a table that helps to immediately differentiate between everyday and medical understanding of the problem. [6]

What the patient usually says	What does this mean in clinical terms?
"I can't live without drops"	A cycle of constant re-use has formed
"The drops help at first, then they stop."	Rebound congestion and tolerance develop
"My nose gets more stuffy without the spray."	Drug-induced rhinitis is possible
"I've been dripping for months now."	The drug is not used according to the instructions and is no longer used as a short-term aid.
"I can't sleep without drops"	There is a risk of chronic swelling of the mucous membrane and concomitant underlying disease

How a vicious circle is formed

The nasal mucosa is rich in blood vessels. When a person uses a vasoconstrictor spray, the vessels constrict, swelling quickly subsides, the nasal passages widen, and breathing becomes easier. This is why such medications are so popular for colds, allergies, and temporary congestion. The rapid effect gives the patient the feeling of having found a simple and reliable solution. [7]

The problem arises when use is prolonged. Several mechanisms are discussed in the literature that may explain the development of drug-induced rhinitis: changes in receptor sensitivity, disruption of vascular neural regulation, reactive vasodilation after the drug's effect wears off, and inflammatory and structural changes in the mucous membrane. A complete, unified explanation remains elusive, but the clinical outcome is consistent: nasal congestion becomes increasingly rapid, and the effect of each dose becomes shorter. [8]

As the condition progresses, the person begins using the medication more frequently, then increasing the dosage, and eventually carrying the bottle with them constantly. This creates not only a physiological but also a behavioral cycle of addiction: the patient fears the nose will "close up" again and uses the spray even before significant congestion occurs. This form of addiction is especially common among people who have long suffered from allergic rhinitis or chronic rhinosinusitis and have not received standard treatment for a long time. [9]

At the tissue level, some patients have reported loss of normal ciliated epithelial function, goblet cell hyperplasia, epithelial edema, increased mucus production, and signs of chronic inflammation. However, authors of clinical reviews emphasize that human histological data remain less clear than those from animal models. This is an important caveat: the clinical condition is well known, but all its microscopic mechanisms have not been fully elucidated. [10]

Modern reviews add another useful clarification. For oxymetazoline and xylometazoline, when used strictly according to the instructions, there is less convincing evidence of drug-induced rhinitis in the first 7-10 days than was long believed. However, in real life, the problem is precisely that many patients exceed the recommended duration and dosage. Therefore, in clinical practice, the main risk is not associated with a single short course, but with deviations from the instructions and self-medication over weeks and months. [11]

The table below shows how this cycle develops step by step. [12]

Stage	What's happening
1	A cold, allergy, or other cause of congestion occurs
2	The patient begins using a vasoconstrictor spray.
3	Gets quick relief and reinforces the habit
4	The effect becomes shorter and the congestion returns.
5	The frequency of use is increasing
6	The mucous membrane is increasingly tolerating the withdrawal
7	Chronic rebound congestion and drug-induced rhinitis occur.

Why the problem doesn't affect everyone and who is at risk?

Precise population figures for rhinitis medicamentosa are scarce because a significant portion of people self-medicate and never consult a doctor. According to a StatPearls review, rhinitis medicamentosa accounts for approximately 1% to 9% of visits to otolaryngology clinics, but this figure is likely underestimated due to the over-the-counter availability of medications. Clinical observations and older outpatient studies also indicate that the problem is not uncommon and may be significantly increasing due to active advertising and easy purchase without consulting a specialist. [13]

This condition is most often described in young and middle-aged adults. This is logical: these groups are more likely to self-medicate, continue working despite symptoms, and seek quick relief without visiting a doctor. But in reality, drug-induced rhinitis can occur at any age if the vasoconstrictor is used for too long. [14]

The main risk factor is not the drug itself, but the duration and regimen of use. Modern clinical and review sources agree that prolonged use, especially longer than a few days and especially longer than a week, significantly increases the risk. In practice, this means that carelessness with the duration of the course is more important than the specific brand name on the packaging. [15]

The second major risk group consists of patients with an untreated underlying cause of nasal congestion. These include allergic rhinitis, chronic rhinosinusitis, non-allergic rhinitis, a deviated septum, polyps, and other conditions that initially impair nasal breathing. If the underlying condition is left untreated, the patient almost inevitably attempts to compensate by increasingly frequent use of a topical decongestant. [16]

Lack of awareness and over-the-counter availability also contribute. In a Canadian survey of otolaryngologists, 75% of specialists found existing package warnings insufficient, and 79% found them insufficiently clear. More recent surveys of consumers and pharmacists also show that a significant proportion of people exceed the recommended use period and are poorly aware of the risk of rebound congestion. [17]

The practical conclusion is simple: dependence on vasoconstrictor drops often develops not due to “weakness of character,” but due to a combination of three factors - chronic congestion, rapid relief after taking the drug, and the lack of a clear plan to treat the underlying cause of the disease. [18]

Below is a table of the main risk factors.[19]

Risk factor	Why is it important?
Use for more than a few days	The risk of rebound congestion is increasing
Self-medication without medical supervision	There is no limit on the duration of the course.
Allergic rhinitis	The underlying inflammation persists and triggers re-use
Chronic rhinosinusitis	The congestion becomes constant
Deviated nasal septum	A mechanical cause makes breathing difficult
Nasal polyps	The spray masks the problem but does not eliminate it.
Poor awareness	The patient is unaware of the safe timeframes

How to understand that medicamentous rhinitis has already developed

The most typical symptom is persistent nasal congestion, which is relieved only after another dose of the decongestant. The effect then becomes progressively shorter-lasting. While initially a bottle would help almost all night, later it must be used more frequently, sometimes every few hours. This shortened relief period is very characteristic of medicamentous rhinitis. [20]

Unlike classic allergic rhinitis, many patients with rhinitis medicamentosa experience nasal congestion rather than itching, sneezing, and watery discharge. A Canadian survey of specialists noted that patients often present with persistent nasal obstruction without severe rhinorrhea, postnasal drip, or persistent sneezing. This isn't an absolute rule, as some people also have allergies, but this symptom profile is very typical for rhinitis medicamentosa. [21]

Over time, nasal congestion can be accompanied by mouth breathing, dry mouth, snoring, sleep disturbances, and daytime fatigue. If a person is unable to breathe through their nose for a long period of time, sleep quality deteriorates, concentration decreases, and irritability increases. For this reason, the problem goes far beyond a "common runny nose" and begins to significantly impair daily life. [22]

Upon examination, the physician may notice edematous mucosa, redness, granularity, and, with longer-term progression, dryness, crusting, and signs of atrophic changes. Hyperplasia of the nasal turbinates and chronic secondary changes in the mucosa have also been described in the literature. However, it is important to remember that no external sign alone confirms the diagnosis unless there is a history of prolonged decongestant use. [23]

There are also warning signs that require not only discontinuing the drops but also an in-person evaluation by a doctor. These include persistent one-sided congestion, severe facial pain, high fever, frequent nosebleeds, foul-smelling discharge, a noticeable decrease in olfactory function, suspicion of polyps, or a lack of improvement after trying to stop the medication. In such cases, it's important to look not only for drug-induced rhinitis but also for concomitant or alternative pathologies. [24]

The table below helps to differentiate the typical picture of drug-induced rhinitis from the usual short-term congestion associated with an infection.[25]

Sign	More indicative of drug-induced rhinitis	More likely to be a common cold.
Duration of the problem	Weeks and months	Usually a few days
Reaction to the spray	It helps, but it's getting shorter.	It helps briefly, but the disease goes away on its own.
Frequency of use	More and more often	Limited short course
Leading symptom	Constant congestion	Runny nose, sore throat, cough, fever
Dream	Often disturbed by the nose	Usually disrupted for a short time
The need to carry the bottle with you	Typical	Not typical

How a doctor makes a diagnosis and what is important not to miss

Drug-induced rhinitis is primarily a clinical diagnosis. There is no specific blood test, smear, or single instrumental test that would automatically "prove" it. The basis for diagnosis is a detailed medical history, a nasal examination, and determining the duration, frequency, and dosage of the patient's vasoconstrictor use. [26]

In a Canadian survey of specialists, 100% of respondents considered the combination of chronic nasal congestion and decongestant use sufficient grounds for diagnosis, while 75% additionally relied on physical signs and endoscopic examination. Radiological imaging is rarely used in routine practice for typical rhinitis medicamentosa. This is important: the diagnosis is most often made without CT scanning if the medical history is typical. [27]

But diagnosis is only half the battle. The doctor must understand why the patient started using the drops in the first place and what continues to cause congestion. Differential diagnoses include allergic rhinitis, non-allergic rhinitis, rhinosinusitis, structural problems of the nasal cavity, polyps, and some rare causes. If they simply state, "You're addicted to the spray," they could miss the underlying condition and quickly relapse after discontinuing the medication. [28]

If an allergy is suspected, the doctor considers seasonality, itching, sneezing, and exposure to allergens, and, if necessary, conducts an allergy examination. For allergic rhinitis, a thorough medical history, examination, and confirmation of sensitization are essential, and long-term treatment consists of nasal glucocorticosteroids and second-generation antihistamines, rather than decongestants. This is especially important for allergic rhinitis, as untreated allergies are often the underlying cause of the problem. [29]

If symptoms are atypical, unilateral, accompanied by purulent discharge, pain, polyps, bleeding, or suspected anatomical obstruction, nasal endoscopy and, in some cases, imaging may be necessary. However, this is no longer a routine procedure, but rather the next step in cases of unclear findings or complicated clinical presentations. [30]

The table below shows which questions actually help a doctor make a correct diagnosis. [31]

Diagnostic question	Why is it needed?
What kind of spray was used?	You need to understand the active ingredient
How long was the drug used?	This is the key to the diagnosis
How many times a day is the spray used?	Helps to assess the degree of dependence on the drug
What was the reason for the start of use?	We need to find the underlying disease.
Is there itching, sneezing, or watery eyes?	Suggests an allergic component
Is there one-sided congestion, blood, pain?	It makes you look for another pathology
What happens when you try to cancel?	Helps to assess the severity of rebound congestion

How is it treated and is it possible to stop using eye drops without surgery?

The basic principle of treatment is simple in formulation but difficult in practice: the vasoconstrictor must be discontinued. This discontinuation is considered the central step of therapy. Patients are always warned that congestion may temporarily worsen after discontinuation, and this does not mean the treatment is not working. On the contrary, such a brief period of worsening is usually an expected part of breaking the vicious cycle. [32]

In practice, two main approaches are used: complete abrupt discontinuation or gradual reduction in frequency of use. In a survey of Canadian otolaryngologists, the most common strategies were discontinuation of the drug or its gradual withdrawal, as well as the concurrent administration of nasal glucocorticosteroids. This reflects real-world clinical practice: there is no universal protocol, but the core treatment is very similar across most specialists. [33]

Nasal glucocorticosteroids are considered the most useful pharmacological support during withdrawal. In a 2019 systematic review, they were the most frequently described treatment, although the overall level of evidence remained limited. A StatPearls review also found that such drugs reduced rebound congestion symptoms in small clinical studies and animal models. [34]

An important clinical point is that nasal glucocorticosteroids do not provide the same immediate effect as a decongestant spray. Their purpose is not to "clear the nose in a minute," but to reduce inflammation and help the mucous membrane return to normal function. Therefore, the difference between a symptomatic, quick-fix remedy and basic anti-inflammatory therapy should be explained to the patient in advance. Without this, many people discontinue treatment too early and return to their usual bottle. [35]

Saline nasal irrigations are often used as an adjunct. While they don't eliminate addiction on their own, they help flush mucus, reduce dryness, and provide mechanical relief during withdrawal. In a Canadian survey, more than half of specialists supported them. For patients, this is an important and safe way to get through the most unpleasant days after decongestant withdrawal. [36]

In some cases, a physician may prescribe a short course of systemic glucocorticosteroids if swelling is severe and the patient needs help relieving severe congestion. However, it's important not to create the false impression that this is the standard for everyone. StatPearls specifically emphasizes that such recommendations are based primarily on limited data and anecdotal reports, rather than a strong evidence base. [37]

Antihistamines help not because they "treat addiction," but because some patients have a concomitant allergic component. If the primary problem is allergic rhinitis, it is significantly more difficult to discontinue the decongestant without its control. Therefore, proper treatment often involves not a single measure, but a combination of decongestant withdrawal and treatment of the underlying condition. [38]

Surgery is not considered a treatment for the actual dependence on drops. However, if severe anatomical obstruction, polyps, chronic rhinosinusitis, or other structural obstruction persists after discontinuing drops and following basic therapy, an otolaryngologist may consider surgical correction for this underlying cause, rather than for the drug-induced rhinitis itself. This is why a good diagnosis before treatment is so important. [39]

Full recovery of the mucous membrane after prolonged abuse can take months, not days. StatPearls indicates that with long-term or prolonged excessive use, full recovery can take up to a year. This doesn't mean a person will experience choking for an entire year without relief, but it explains why the mucous membrane returns to normal function gradually, rather than instantly. [40]

The table below shows what the treatment typically looks like in stages. [41]

Treatment stage	What do they usually do?
1	They explain the mechanism of the disease and warn about temporary deterioration after discontinuation.
2	Stop taking the drug immediately or gradually reduce the frequency of use.
3	A nasal glucocorticosteroid is prescribed
4	Add saline irrigation for comfort and mucosal care
5	If necessary, treat allergies, rhinosinusitis, or another underlying cause.
6	In severe cases, systemic therapy is briefly considered at the discretion of the physician.
7	In case of persistent anatomical obstruction, referral to an otolaryngologist

What to do at home, when to see a doctor, and how to prevent a relapse

If a dependence on decongestant drops has already developed, self-medication based on the "I'll get through it myself" principle isn't always the best option, but there's no need to panic. In uncomplicated cases, the first rational step is to stop uncontrolled use of the decongestant and switch to a safer maintenance regimen with saline irrigation and a nasal glucocorticosteroid, if recommended by a doctor. The key is not to expect immediate results from basic therapy, as with a decongestant. [42]

You should consult a doctor if the drops are used for more than a few days and your nose becomes practically congested without them. An in-person consultation is especially necessary in cases of frequent relapses, severe nighttime congestion, severe snoring, impaired sense of smell, suspected allergies, polyps, chronic rhinosinusitis, or a deviated septum. In these situations, it's important not only to discontinue the spray but also to understand what's causing the chronic congestion. [43]

Urgent or more rapid evaluation is required if nosebleeds, severe one-sided congestion, high fever, severe facial pain, nasal odor, a noticeable deterioration in general condition, or a lack of response to discontinuation of the drops are present, despite increasing symptoms. Infectious and other causes that cannot be explained by dependence on the drops alone must be ruled out. [44]

Relapse prevention is based on two principles. First, use decongestants only for short periods. Second, treat the underlying cause of nasal congestion. For allergic rhinitis, the mainstay of therapy remains nasal glucocorticosteroids and second-generation antihistamines, and, if necessary, allergen-specific immunotherapy. If the underlying condition is not addressed, the risk of relapse remains high. [45]

Another important detail from clinical reviews: repeated short courses of abuse can reactivate rhinitis medicamentosa even after a previous recovery. Therefore, it is especially important for someone who has already fallen into this trap to remember the timing and avoid using such remedies "just in case" or before bedtime. [46]

The table below summarizes the practical plan for the patient.[47]

Situation	What is reasonable to do?
Using the spray has already become a daily routine.	Plan your withdrawal and see a doctor
Stuffy nose after discontinuation	Don't consider this a failure, but understand it as an expected phase
There is an allergy	Start or adjust basic antiallergic therapy
There is a suspicion of polyps or a deviated septum	An examination by an otolaryngologist is required.
I've needed the drops for months now.	What is needed is a diagnosis of the underlying cause, not a new bottle.
There was an episode of addiction in the past	Use decongestants in the future only very briefly and with caution.

Frequently Asked Questions

Is it possible to become accustomed to drops in as little as 3 days?
Classic reviews describe that rebound congestion can appear as early as 3 days, although the exact timeframe is debated in the literature and depends on the molecule, dose, and administration schedule. More recent reviews indicate that with strict short-term use of modern medications, the risk may be lower, but the rule of thumb remains conservative: use such medications only for very short periods. [48]

Is this a true addiction or just a habit?
From a medical perspective, it's more accurate to talk about medicamentous rhinitis and behavioral dependence on rapid symptom relief, rather than classic chemical dependency. A recent study hasn't shown an increased susceptibility to other addictive substances in such patients, but a clinical cycle of repeated use does exist. [49]

Is it better to quit immediately or gradually reduce the frequency of use?
There is no single, mandatory method. In practice, both complete discontinuation and gradual reduction in frequency of use are used. A survey of Canadian otolaryngologists showed that both approaches are used, and most often they are combined with nasal glucocorticosteroids. [50]

How long will withdrawal symptoms last?
The most unpleasant symptoms usually occur early in withdrawal, when congestion temporarily worsens. However, full recovery of the mucous membrane after prolonged abuse can take significantly longer, up to months, and according to some sources, up to 1 year with prolonged excessive use. [51]

Is it possible to treat with saline irrigation alone?
Saline irrigations are useful as an adjunctive measure, but they do not replace the need to discontinue vasoconstrictors or resolve chronic inflammation if there is an allergy or other underlying condition. They are most often used as part of a broader regimen. [52]

If the cause is an allergy, will decongestant drops alone help?
No. For allergic rhinitis, nasal glucocorticosteroids are considered the mainstay of long-term therapy, along with second-generation antihistamines and immunotherapy if needed. Decongestants may provide short-term relief, but do not control the allergic inflammation itself. [53]

When is it absolutely necessary to see an otolaryngologist?
When there's a long-term dependence on drops, suspected polyps, severe anatomical congestion, frequent relapses, ineffective withdrawal, nosebleeds, unilateral symptoms, or signs of chronic rhinosinusitis. In such cases, what's needed is not just advice to "avoid using drops," but a full examination and clarification of the cause of the obstruction. [54]

Key points from experts

Emad Masood, Professor of Otolaryngology at Dalhousie University, Canada.
Based on a nationwide survey of otolaryngologists, his team found that in real-world clinical practice, treatment for rhinitis medicamentosa most often revolves around discontinuing or gradually tapering off decongestants and concomitantly prescribing nasal glucocorticosteroids. Masood's second key finding is that specialists consider current package warnings insufficiently visible and understandable to patients. [55]

Ronald Eccles, Emeritus Professor at Cardiff University and founder of the Common Cold Centre, is a key figure in this study.
Eccles's work and more recent reviews of decongestants help maintain an important balance: topical decongestants can be effective and safe when used correctly in the short term, but the risk increases dramatically with irregular use and prolonged use. His scientific perspective is particularly useful because it doesn't demonize the drugs themselves, but rather shifts the focus to appropriate use and abuse prevention. [56]

Anne K. Ellis, Professor and Director of the Division of Allergy and Clinical Immunology at Queen's University, Canada.
The key thesis of Ellis and co-authors in a modern review of allergic rhinitis is that long-term symptom control should rely on anti-inflammatory, disease-modifying therapy, primarily nasal glucocorticosteroids, rather than chronic use of decongestants. For patients with nasal drip dependence, this is crucial: without treatment of the underlying allergy, the risk of relapse to decongestant nasal sprays remains very high. [57]

Conclusion

Dependence on decongestant drops is, in most cases, a form of medicamentous rhinitis, or chronic rebound nasal congestion caused by excessive or prolonged use of topical decongestants. This condition should not be confused with the patient's personality or a purely psychological problem. It is based on a truly vicious cycle: a rapid drug effect, a return of swelling, even more frequent use, and the habit becoming entrenched. [58]

The key to recovery is not to seek out new, "stronger" drops, but to discontinue use of the decongestant, support the mucous membrane with basic therapy, and be sure to identify the underlying cause of chronic nasal congestion. Most often, this is allergic rhinitis, non-allergic rhinitis, rhinosinusitis, or an anatomical problem with the nasal cavity. Without addressing the underlying cause, even successful discontinuation of the bottle can easily lead to a relapse. [59]

The most practical conclusion for everyday life is simple: decongestant drops are a short-term relief measure, not a long-term cure. The sooner a patient understands this, the less likely they are to go from a common cold or allergy to months of chronic congestion and living "with a bottle in their pocket." [60]